摘要
目的将生物制剂应用在风湿免疫疾病的治疗中,从其临床应用效果对其临床应用价值进行分析和研究。方法对某院于2011年8月～2012年8月接受治疗的23例风湿免疫患者进行临床研究。将23例患者随机分为治疗组和对照组,分别为12例和11例。对治疗组采用生物制剂进行治疗,对照组采用常规治疗方法,对两组的临床治疗效果进行对比分析。结果在对风湿免疫病的治疗中,对照组和治疗组均取得了较好的治疗效果,但是与对照组相比,治疗组的治疗效果具有更明显的效果。结论根据两组的治疗效果分析,我们发现在治疗风湿免疫病中采用生物制剂更具有针对性,具有更高的临床应用价值,不仅降低了患者的痛苦、提升了患者的生活质量,还提高了治疗的安全性。
Objective To apply biological agents in the treatment of rheumatic and immune disease,analyze and study the clinical application value by effect. Methods 23 cases of rheumatic and immune patients from August 2011 to August 2012 in some hospital were studied. 23 patients were randomly divided into two groups respectively：the treatment group of 12 cases and the control group of 11 cases.The treatment group were used biological agents for treatment,the control group were used conventional treatment methods,clinical therapeutic effect of two groups were compared and analyzed. Results In treatment of rheumatic and immune disease,the treatment group and the control group achieved good therapeutic effect,but the therapeutic effect of the treatment group was more obvious compared to the control group. Conclusion According to curative effect analysis results of two groups,we found that the biological agents are more targetedly used in the treatment of rheumatic and immune disease,which have higher clinical application value,not only reduce the pain of patients,improve the life quality of patients,but also improve the safety of treatment.
出处
《中国医药科学》
2013年第9期86-87,共2页
China Medicine And Pharmacy
关键词
风湿免疫病
生物制剂
临床应用研究
Rheumatic and immune disease
Biological agents
Clinical application study
